Daniel Cejka

Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy

Wolfgang Sieghart, Doris Losert, Sabine Strommer et al. · Journal of Hepatology · 2005 · 252 citations · Full text

Medicine, Cancer Biology, Oncology +17

Sclerostin and Dickkopf-1 in Renal Osteodystrophy

Daniel Cejka, Johann Herberth, Adam J. Branscum et al. · Clinical Journal of the American Society of Nephrology · 2010 · 242 citations · Full text

Medicine, Endocrinology, Nephrology +17

Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis

Daniel Cejka, Silvia Hayer, Birgit Niederreiter et al. · Arthritis & Rheumatism · 2010 · 171 citations

Medicine, Immunology, Pathobiology +17

Mammalian Target of Rapamycin Pathway Activity in Hepatocellular Carcinomas of Patients Undergoing Liver Transplantation

Wolfgang Sieghart, Thorsten Fuereder, Katharina Schmid et al. · Transplantation · 2007 · 155 citations

Medicine, Oncology, Pharmacology +17

Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients

Daniel Cejka, A. Jäger-Lansky, Heidi Kieweg et al. · Nephrology Dialysis Transplantation · 2011 · 148 citations · Full text

Medicine, Endocrinology, Nephrology +17